Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Cohort Study: Thromboembolic risk in patients with pneumonia and new-onset atrial fibrillation not receiving anticoagulation therapy.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Cohort Study: Thromboembolic risk in patients with pneumonia and new-onset atrial fibrillation not receiving anticoagulation therapy.

Cohort Study: Thromboembolic risk in patients with pneumonia and new-onset atrial fibrillation not receiving anticoagulation therapy.

Zouhair Souissi

Bibliographie

27 mai 2022

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy – JAMA Network Open

The post Cohort Study: Thromboembolic risk in patients with pneumonia and new-onset atrial fibrillation not receiving anticoagulation therapy. appeared first on Links Medicus.

Lu 591 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening. M-A: Efficacy of physiotherapy interventions on weaning in mechanically ventilated critically ill patients. »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche